Abstract:
The present invention is directed to compounds of Formula (I) which are modulators of chemokine receptors. The compounds of the invention, and compositions thereof, are useful in the treatment of diseases related to chemokine receptor expression and/or activity.
Abstract:
A flame resistant fabric having a high level of pilling resistance and good strength characteristics is described. In addition, a method of making the fabric is also described.
Abstract:
The present invention is directed to compounds of Formula (I) which are modulators of chemokine receptors. The compounds of the invention, and compositions thereof, are useful in the treatment of diseases related to chemokine receptor expression and/or activity.
Abstract:
A flame resistant fabric having a high level of pilling resistance and good strength characteristics is described. In addition, a method of making the fabric is also described.
Abstract:
A portable roof panel structure assembly mechanism (100) that may be transported to a construction site and that is used to automatically assemble roof panel structures at the site. The assembly mechanism includes a purlin feeder (102), subpurlin clamping mechanisms (106) and feeders (104), and a diaphragm feeder (108). The purlin feeder (102) lifts a purlin into position, and advances the purlin into an assembly station (110). The subpurlin feeders (104) insert a subpurlin into each of a plurality of subpurlin clamping mechanisms, and the clamping mechanisms advance into the assembly station (110) and hold the subpurlins against the section of the purlin that has been advanced. The diaphragm feeder (108) places a diaphragm onto the subpurlins and the purlin at the assembly station (110). The components are attached by automatic nailers.
Abstract:
The present invention provides heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines of Formula I: wherein X, Y, Z, L, A, R 5 , n, m, and r are defined above, as well as their compositions and methods of use, that modulate the activity of Janus kinases (JAKs) and are useful in the treatment of diseases related to the activity of JAKs including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
Abstract:
The present invention is directed to compounds of Formula (I): which are modulators of chemokine receptors. The compounds of the invention, and compositions thereof, are useful in the treatment of diseases related to chemokine receptor expression and/or activity.
Abstract:
The present invention relates to modulators of HM74a receptor, and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with HM74a receptor.
Abstract:
The present invention relates to compounds of Formula (I): wherein variable substituents are defined herein, that modulate the activity of or bind to chemokine receptors such as CCR5. In some embodiments, the compounds of the invention are selective for CCR5. The compounds can be used, for example, to treat diseases associated with chemokine receptor expression or activity such as inflammatory diseases, immune diseases and viral infections.
Abstract:
The present invention is directed to compounds of Formula (I) : which are modulators of chemokine receptors. The compounds of the invention, and compositions thereof, are useful in the treatment of diseases related to chemokine receptor expression and/or activity.